Similarly, Wegovy received a secondary indication in March 2024 to reduce the risk of cardiovascular death, heart attack and stroke in adults with cardiovascular disease and either obesity or overweight
We Love the Reef: This product is made without Oxybenzone or Octinoxate to help protect fragile reef ecosystems
Chronic fatigue (anecdotal): Many with ME/CFS report problems with mast cell activation or histamine intolerance symptoms
Improved Glucose Tolerance in Rats Treated With the Dipeptidyl Peptidase IV (CD26) Inhibitor Ile-Thiazolidide
#epilepsy #ilae #epilepsiaOpen #Alzheimersdisease #cerebrovasculardisease #elderly #lateonsetepilepsy #neurodegenerative disease To view or add a comment, sign in Baxdrostat could become a major step forward for people whose blood pressure stays high despite treatment and delay the progression of kidney disease Results from the FigHTN Phase 2 clinical trial showed baxdrostat, a new medication that inhibits the production of the hormone aldosterone, lowered systolic blood pressure by about 5% when added to the existing medications taken by people with chronic kidney disease and who also have uncontrolled high blood pressure To view or add a comment, sign in Working on voltage-gated calcium (CaV) channels
Our goal is to offer personalized guidance and support while helping patients make informed decisions about their nutritional and wellness care
